Drug Information

Drug General Information
Drug ID
D0L1IS
Former ID
DNC013757
Drug Name
NOR-ROEFRACTINE
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534656]
Formula
C18H21NO3
Canonical SMILES
COC1=CC=C(C=C1)CC2C3=CC(=C(C=C3CCN2)O)OC
InChI
1S/C18H21NO3/c1-21-14-5-3-12(4-6-14)9-16-15-11-18(22-2)17(20)10-13(15)7-8-19-16/h3-6,10-11,16,19-20H,7-9H2,1-2H3/t16-/m1/s1
InChIKey
HIMHLENXDBHLCU-MRXNPFEDSA-N
PubChem Compound ID
7055406
Target and Pathway
Target(s) D(2) dopamine receptor Target Info Inhibitor [534656]
KEGG Pathway Rap1 signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Alcoholism
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathway
Reactome Dopamine receptors
G alpha (i) signalling events
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
Nicotine Activity on Dopaminergic Neurons
References
Ref 534656J Nat Prod. 1998 Jun 26;61(6):709-12.Synthesis and dopamine receptor selectivity of the benzyltetrahydroisoquinoline, (R)-(+)-nor-roefractine.
Ref 534656J Nat Prod. 1998 Jun 26;61(6):709-12.Synthesis and dopamine receptor selectivity of the benzyltetrahydroisoquinoline, (R)-(+)-nor-roefractine.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.